2024 Dyne therapeutics market cap

Dyne therapeutics market cap

Author: effn

August undefined, 2024

WebYou can buy and sell Dyne Therapeutics (DYN) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. ... Market cap. 628.17M. Market cap 628.17M. Price-Earnings ratio-3.44. WebApr 6, 2024 · With Dyne Therapeutics stock trading at $15.00 per share, the total value of Dyne Therapeutics stock (market capitalization) is $845.07M. Dyne Therapeutics …

DYN - Dyne Therapeutics, Inc. Stock Price and Quote - FINVIZ.com

WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases. WebApr 12, 2024 · Market Cap Chart Since the IPO on September 17, 2024, Dyne Therapeutics, Inc.'s market cap has decreased from $790.90M to $480.56M, a … blm tucson office

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus …

WebDyne Therapeutics, Inc. Analyst Report: Xcel Energy Inc. Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Discover historical prices for DYN stock on Yahoo Finance. View daily, weekly or … Get the detailed quarterly/annual income statement for Dyne Therapeutics, Inc. … View the basic DYN option chain and compare options of Dyne Therapeutics, … Find out the direct holders, institutional holders and mutual fund holders for … Dyne Therapeutics, Inc. 1560 Trapelo Road Waltham, MA 02451 United States 781 … See Dyne Therapeutics, Inc. (DYN) stock analyst estimates, including earnings … Find out all the key statistics for Dyne Therapeutics, Inc. (DYN), including … Dyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, … See Dyne Therapeutics, Inc. (DYN) Environment, Social and Governance … Find the latest Dyne Therapeutics, Inc. (DYN) stock quote, history, news and … WebMarket Cap ‎781.90M. Shares Outstanding ‎52.13M. EPS (TTM) ‎-3.2357. P/E (TTM) ‎-Fwd Dividend (% Yield) ‎-Ex-Dividend Date ‎- ... Dyne Therapeutics Inc. is a muscle disease company ... WebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ. blm trend chart

DYN - Dyne Therapeutics Stock Price - Barchart.com

Dyne therapeutics market cap

Investors & Media Dyne Therapeutics, Inc.

WebDyne Therapeutics Inc market cap is $489.02M. What is the 52-week high for Dyne Therapeutics Inc? 52 week high is the highest price of a stock in the past 52 weeks, or … WebJan 27, 2024 · With a market capitalization of US$963m, Dyne Therapeutics is a decent size, so it is probably on the radar of institutional investors. In the chart below, we can see that institutions own shares ...

Did you know?

WebFind real-time DYN - Dyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Market cap: $528.5M: Data as of 3:59pm ET, 04/10/2024. Growth & Valuation. WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. Use the PitchBook Platform to explore the full profile. Information on stock, financials, earnings, subsidiaries, investors, and executives for Dyne Therapeutics. ... Market Cap Shares Average Volume EPS; $9.38: $9.11: $4.30 - $15.63 ...

WebApr 11, 2024 · Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Rating) have earned an average rating of "Moderate Buy" from the seven ratings firms that are … WebFeb 28, 2024 · Latest Dyne Therapeutics Inc Stock News. As of February 28, 2024, Dyne Therapeutics Inc had a $681.8 million market capitalization, putting it in the 59th percentile of companies in the Biotechnology & Medical Research industry. Dyne Therapeutics Inc does not have a meaningful P/E due to negative earnings over the last …

WebApr 11, 2024 · Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Rating) have earned an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the stock, MarketBeat.com reports. ... The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. The business has a 50 day … WebGet the latest Dyne Therapeutics Inc (DYN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …

WebApr 5, 2024 · Dyne Therapeutics, Inc. Common Stock (DYN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

WebMar 24, 2024 · Dyne Therapeutics Inc Registered Shs's market capitalization is $642.40 M by 56.34 M shares outstanding. Dyne Therapeutics Stock Snapshot 11.04 free audio looping software for windowsWebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that … free audio loop samplesWebMar 29, 2024 · Get a real-time Dyne Therapeutics, Inc. (DYN) stock price quote with breaking news, financials, statistics, charts and more. ... Market Cap: 628.17M: Revenue (ttm) n/a: Net Income (ttm)-168.10M: Shares Out 56.34M: EPS (ttm)-3.23: PE Ratio ... Chardan Initiates Coverage On These 'Intriguing Small-Cap Stories" Chardan Research … free audiomack plays increaserWebApr 10, 2024 · Dyne Therapeutics Inc. company and executive profile by Barron's. View the latest DYN company infomation and executive bios. free audiomack promotionWebApr 11, 2024 · Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven … free audio looping softwareWebDyne Therapeutics Inc Working Capital Per Revenue on the trailing twelve month basis from the forth quarter 2024 to forth quarter 2024, Trends and Ranking, Fundamental Ratios - CSIMarket Company Name, Ticker, Suppliers, else.. free audio marathi booksWebReal time Dyne Therapeutics (DYN) stock price quote, stock graph, news & analysis. free audio meditation downloads